[continued from previous message]

GSK: New kind of drug, but I do not know what it does: Drugs, possibly novel ions, ionic few AMU organic chemicals, or even things like lopsided quantum dots with charge anisotropy, could cause beneficial protein or other molecule specific nucleation
effects at cytes, and tissues, notably at a variety of body structures, wikipedia notes that actin tubules come from nucleation, “Energy consuming self-organising systems such as the microtubules in cells also show nucleation and growth.” So they
could make a bunch of things that are likely to cause nucleation, screen a library of thousands (or millions or billions) of them at a yeast or human tissue biochip, and see which if any any of them caused greater longevity, wellness, as well as
healthspan, previously described is how if you genetically engineer yeast to make more green fluorescent protein then the longer it lives, then you can find the longest lived yeast at something like a big array of wells (a billion or more) on a microchip,
where each well has a different chemical and yeast growth medium, and a camera looks at the whole array, and then finds the row and column with the brightest glowing (longest lived) yeast at it. 10 million cyte per second microfluidics flow cytometry is
also published and that approach could also be used to screen a billion new nucleation drugs as to longevity, wellness, and healthspan effects at a billion yeast in 100 seconds, or a trillion, to produce a high n P value, in 27.7 hours at one machine.
Also, lopsided quantum dots, stabilizing molecules (a little like, but perhaps quite different than antioxidants) few amu molecules, as well as things like eentsiest cyclodextrins, topological starches, and things like graphene toruses, and chelation
molecules, could see the effect of reducing nucleation at biochip screened libraries on things like yeast and human tissue culture; notably wikipedia says amyloid blobs at alzheimers accumulate from nucleation, so it is possible there are a variety of
nucleation reduction effects which could be beneficial at a variety of human body tissues; Interestingly, as to cryopreservation, novel nucleation producers, reducers, or customizers could benefit cryopreservation of human bodies, freezable and thawable
living organisims exist, and these may have numerous simultaneous nucleation, causing, reducing, or modulating chemicals besides comparatively macroquantity chemicals like trehalose at them that people could find, and quantify as to cryopreservation
benefit.

--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)